A carregar...
In vivo and in vitro assessment of mirtazapine pharmacokinetics in cats with liver disease
BACKGROUND: Liver disease (LD) prolongs mirtazapine half‐life in humans, but it is unknown if this occurs in cats with LD and healthy cats. HYPOTHESIS/OBJECTIVES: To determine pharmacokinetics of administered orally mirtazapine in vivo and in vitro (liver microsomes) in cats with LD and healthy cats...
Na minha lista:
| Publicado no: | J Vet Intern Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6272035/ https://ncbi.nlm.nih.gov/pubmed/30307637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.15237 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|